Activated Src kinases interact with the N-methyl-D-aspartate receptor after neonatal brain ischemia

Annals of Neurology

Volumn 63, Issue 5, 2008, Pages 632-641

  Jiang, Xiangning ^a,b   Mu, Dezhi ^a,b   Biran, Valerie ^c   Faustino, Joel ^a   Chang, Shengjun ^a   Rincón, Christina M ^d   Sheldon, R Ann ^a   Ferriero, Donna M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SICHUAN UNIVERSITY   (China)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN KINASE FYN; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NEWBORN; PATHOLOGY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; BRAIN ISCHEMIA; ENZYME ACTIVATION; MICE; NEUROPROTECTIVE AGENTS; PYRIMIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TREATMENT OUTCOME;

EID: 44849112514     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21365     Document Type: Article

References (46)

1. Ferriero DM. Neonatal brain injury. N Engl J Med 2004;351:1985-1995.
2. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol 2004;3:150-158.
3. Nelson KB. Perinatal ischemic stroke. Stroke 2007;38:742-745.
4. Raju TN, Nelson KB, Ferriero D, Lynch JK. Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 2007;120:609-616.
5. Johnston MV. Excitotoxicity in perinatal brain injury. Brain Pathol 2005;15:234-240.
6. Johnston MV. Excitotoxicity in neonatal hypoxia. Ment Retard Dev Disabil Res Rev 2001;7:229-234.
7. Hansen HH, Briem T, Dzietko M, et al. Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 2004;16:440-453.
8. Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999;283:70-74.
9. Sheng M, Pak DT. Glutamate receptor anchoring proteins and the molecular organization of excitatory synapses. Ann N Y Acad Sci 1999;868:483-493.
10. Kennedy MB. The postsynaptic density at glutamatergic synapses. Trends Neurosci 1997;20:264-268.
11. Martone ME, Jones YZ, Young SJ, et al. Modification of postsynaptic densities after transient cerebral ischemia: a quantitative and three-dimensional ultrastructural study. J Neurosci 1999;19:1988-1997.
12. Domanska-Janik K, Zalewska T, Zablocka B, Ostrowski J. Ischemia-induced modifications of protein components of rat brain postsynaptic densities. Neurochem Int 1999;34:329-336.
13. Hu BR, Park M, Martone ME, et al. Assembly of proteins to postsynaptic densities after transient cerebral ischemia. J Neurosci 1998;18:625-633.
14. Jiang X, Mu D, Sheldon RA, et al. Neonatal hypoxia-ischemia differentially upregulates MAGUKs and associated proteins in PSD-93-deficient mouse brain. Stroke 2003;34:2958-2963.
15. Takagi N, Shinno K, Teves L, et al. Transient ischemia differentially increases tyrosine phosphorylation of NMDA receptor subunits 2A and 2B. J Neurochem 1997;69:1060-1065.
16. Cheung HH, Takagi N, Teves L, et al. Altered association of protein tyrosine kinases with postsynaptic densities after transient cerebral ischemia in the rat brain. J Cereb Blood Flow Metab 2000;20:505-512.
17. Takagi N, Cheung HH, Bissoon N, et al. The effect of transient global ischemia on the interaction of Src and Fyn with the N-methyl-D-aspartate receptor and postsynaptic densities: possible involvement of Src homology 2 domains. J Cereb Blood Flow Metab 1999;19:880-888.
18. Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 2004;5:317-328.
19. Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol 2001;11:336-342.
20. Stein PL, Vogel H, Soriano P. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev 1994;8:1999-2007.
21. Hou XY, Zhang GY, Zong YY. Suppression of postsynaptic density protein 95 expression attenuates increased tyrosine phosphorylation of NR2A subunits of N-methyl-D-aspartate receptors and interactions of Src and Fyn with NR2A after transient brain ischemia in rat hippocampus. Neurosci Lett 2003;343:125-128.
22. Chen M, Hou X, Zhang G. Tyrosine kinase and tyrosine phosphatase participate in regulation of interactions of NMDA receptor subunit 2A with Src and Fyn mediated by PSD-95 after transient brain ischemia. Neurosci Lett 2003;339:29-32.
23. Hou XY, Zhang GY, Yan JZ, et al. Activation of NMDA receptors and L-type voltage-gated calcium channels mediates enhanced formation of Fyn-PSD95-NR2A complex after transient brain ischemia. Brain Res 2002;955:123-132.
24. Tezuka T, Umemori H, Akiyama T, et al. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci U S A 1999;96:435-440.
25. Gurd JW, Bissoon N, Beesley PW, et al. Differential effects of hypoxia-ischemia on subunit expression and tyrosine phosphorylation of the NMDA receptor in 7- and 21-day-old rats. J Neurochem 2002;82:848-856.
26. Sheldon RA, Sedik C, Ferriero DM. Strain-related brain injury in neonatal mice subjected to hypoxia-ischemia. Brain Res 1998;810:114-122.
27. Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131-141.
28. Carlin RK, Grab DJ, Cohen RS, Siekevitz P. Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J Cell Biol 1980;86:831-845.
29. van den Tweel ER, Kavelaars A, Lombardi MS, et al. Bilateral molecular changes in a neonatal rat model of unilateral hypoxic-ischemic brain damage. Pediatr Res 2006;59:434-439.
30. Jiang X, Mu D, Manabat C, et al. Differential vulnerability of immature murine neurons to oxygen-glucose deprivation. Exp Neurol 2004;190:224-232.
31. Yaka R, Thornton C, Vagts AJ, et al. NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1. Proc Natl Acad Sci U S A 2002;99:5710-5715.
32. Roskoski R Jr. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 2004;324:1155-1164.
33. Petralia RS, Sans N, Wang YX, Wenthold RJ. Ontogeny of postsynaptic density proteins at glutamatergic synapses. Mol Cell Neurosci 2005;29:436-452.
34. Wyneken U, Smalla KH, Marengo JJ, et al. Kainate-induced seizures alter protein composition and N-methyl-D-aspartate receptor function of rat forebrain postsynaptic densities. Neuroscience 2001;102:65-74.
35. Tang X, Feng Y, Ye K. Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-kinase enhancer-activating Akt, preventing its apoptotic cleavage and promoting cell survival. Cell Death Differ 2007;14:368-377.
36. Werdich XQ, Penn JS. Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. Angiogenesis 2005;8:315-326.
37. Rong Y, Lu X, Bernard A, et al. Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially modulates their susceptibility to calpain and enhances their binding to spectrin and PSD-95. J Neurochem 2001;79:382-390.
38. Lauri SE, Taira T, Rauvala H. High-frequency synaptic stimulation induces association of fyn and c-src to distinct phosphorylated components. Neuroreport 2000;11:997-1000.
39. Gee CE, Benquet P, Raineteau O, et al. NMDA receptors and the differential ischemic vulnerability of hippocampal neurons. Eur J Neurosci 2006;23:2595-2603.
40. Lennmyr F, Ericsson A, Gerwins P, et al. Src family kinase-inhibitor PP2 reduces focal ischemic brain injury. Acta Neurol Scand 2004;110:175-179.
41. Paul R, Zhang ZG, Eliceiri BP, et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001;7:222-227.
42. Khanna S, Roy S, Park HA, Sen CK. Regulation of c-Src activity in glutamate-induced neurodegeneration. J Biol Chem 2007;282:23482-23490.
43. Ardizzone TD, Zhan X, Ander BP, Sharp FR. SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage. Stroke 2007;38:1621-1625.
44. Aarts M, Liu Y, Liu L, et al. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 2002;298:846-850.
45. Trevino JG, Summy JM, Gallick GE. SRC inhibitors as potential therapeutic agents for human cancers. Mini Rev Med Chem 2006;6:681-687.
46. Kalia LV, Pitcher GM, Pelkey KA, Salter MW. PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex. Embo J 2006;25:4971-4982.